Active ingredient: 1 tablet contains 400 mg albendazole.
It is indicated for the treatment of parenchymatous neurocysticercosis caused by the larval (cystic) forms of the pork tapeworm (Taenia solium) in the liver, lungs, and peritoneum, and for the treatment of cystic-hydatid disease caused by the larval (cystic) forms of the dog tapeworm (Echinococcus granulosus).
Hypersensitivity to benzimidazole derivatives or to any component of the product. Pregnancy and pregnancy planning.
Pregnancy: Adequate and well-controlled studies on the use of Albendazole in pregnant women have not been conducted. Albendazole tablets are not recommended for use in pregnant women, except in cases where no appropriate alternative treatment is available. Before prescribing albendazole tablets to women with reproductive potential, a pregnancy test must be performed. Women with reproductive potential (childbearing potential) should be advised to use effective contraception methods during treatment and for 1 month after discontinuation of treatment.
If the patient becomes pregnant while using this product, the administration of the product must be stopped immediately. If the patient becomes pregnant while using this product, she should be informed about the potential risk to the fetus. Lactation: In animals, albendazole is excreted in milk. However, it is not known whether it is excreted in human breast milk.
It is not recommended to prescribe the product during lactation.
Albendazole has no effect on the ability to drive vehicles and operate other potentially dangerous machinery.
The dosage of Albendazole tablets varies depending on the indication. Albendazole tablets can be crushed or chewed and swallowed with water. Albendazole tablets should be taken during meals. Indications: Patient body weight | Dose | Treatment duration. Hydatid disease: 60 kg or more — 400 mg twice daily, with food, 28-day cycle followed by a 14-day albendazole-free interval; total 3 cycles. Less than 60 kg — 15 mg/kg/day.
This dose should be divided into two equal doses and taken twice daily with meals (maximum total daily dose 800 mg). Neurocysticercosis: 60 kg or more — 400 mg twice daily, with food, for 8 to 30 days. Less than 60 kg — 15 mg/kg/day. This dose should be divided into two equal doses and taken twice daily with meals (maximum total daily dose 800 mg).
Product Filters | ||
|---|---|---|
| Supplier Product Code | : | 111-24877 |